Capicua mediates interleukin-2 withdrawal–induced death of activated CD8+ T cells
Cell Insight · 2026-06 · 5 (3) · 100323
DOI: 10.1016/j.cellin.2026.100323 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Insight, 2026-06. Verfasst von Jun-Ge Shi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Medical Research Institute, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, 430071, Hubei, China. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, Ministry of Science and Technology of the People's Republic of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Infectious Diseases, Medical Research Institute, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, 430071, Hubei, China.
- Frontier Science Center for Immunology and Metabolism, State Key Laboratory of Virology and Biosafety, Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan, 430071, Hubei, China.
Förderung
- Fundamental Research Funds for the Central Universities
- Ministry of Science and Technology of the People's Republic of China
Zitieren
APA
Shi, J. G., Xu, Y., Hang, W. H., Zhang, X. Y., Ma, Z. W., & Li, S. (2026). Capicua mediates interleukin-2 withdrawal–induced death of activated CD8+ T cells. Cell Insight, 5(3), 100323. https://doi.org/10.1016/j.cellin.2026.100323
Vancouver
Shi JG, Xu Y, Hang WH, Zhang XY, Ma ZW, Li S. Capicua mediates interleukin-2 withdrawal–induced death of activated CD8+ T cells. Cell Insight. 2026;5(3):100323. doi:10.1016/j.cellin.2026.100323
BibTeX
@article{Shi2026,
author = {Shi, Jun-Ge and Xu, Ye and Hang, Wen-Hao and Zhang, Xin-Yue and Ma, Zhen-Wu and Li, Shu},
title = {Capicua mediates interleukin-2 withdrawal–induced death of activated CD8+ T cells},
journal = {Cell Insight},
year = {2026},
volume = {5},
number = {3},
pages = {100323},
doi = {10.1016/j.cellin.2026.100323}
}
EUVIMED